pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
368
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
DR/DME Program
Diabetic Macular Edema
Ceramedix Holding LLC
Phase 2
DSP-3077
Retinitis Pigmentosa (Retinitis)
Sumitomo Pharma Co Ltd
Phase 1
DST-2105
Keratoconjunctivitis Sicca (Dry Eye)
DelSiTech Ltd
Preclinical
← prev
page 5 of 13
next →
Pain
89
Neurology
1
DT-003
Open-Angle Glaucoma
Diorasis Therapeutics
Phase 2
DT-168
Fuchs Endothelial Corneal Dystrophy (FECD)
$DSGN
Design Therapeutics, Inc.
Phase 1
EB-105
Diabetic Macular Edema
Eluminex Biosciences Ltd
Preclinical
EG-201
Wet (Neovascular / Exudative) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
Phase 1
EG-301
Dry (Atrophic) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
Preclinical
EG-401
Diabetic Retinopathy
Shenzhen Evergreen Therapeutics Co Ltd
Preclinical
EG-402
Retinopathy Of Prematurity
Shenzhen Evergreen Therapeutics Co Ltd
Preclinical
EG-Mirotin
Diabetic Retinopathy
EyeGene Inc
Preclinical
EIR-0205
Dry (Atrophic) Macular Degeneration
EIR Biopharma Inc
Preclinical
EIR-1003
Neovascular Glaucoma
EIR Biopharma Inc
Preclinical
EMD-202
Retinitis Pigmentosa (Retinitis)
EmendoBio Inc
Phase 3
ENB-106
Diabetic Retinopathy
Ennovabio
Phase 1
EO-2002
Corneal Edema
Emmecell LLC
Phase 1
ER-100
Non-Arteritic Anterior Ischemic Optic Neuropathy
Life Biosciences Inc.
Preclinical
Emtin-B
Glaucoma
NeuroScientific Biopharmaceuticals Ltd
Marketed
Eryped
E.E.S. (erythromycin [INN])
Acute Intestinal Amoebiasis
Carnegie Pharmaceuticals LLC
Preclinical
FLQ-105
Geographic Atrophy
Feliqs Corp
Marketed
Flarex
Flarex (fluorometholone acetate)
Anterior Segment Inflammation
$HROW
HARROW, INC.
Preclinical
GF-103
Wet (Neovascular / Exudative) Macular Degeneration
HLB Genex Inc
Phase 2
GLK-221
Keratoconus
$GKOS
GLAUKOS Corp
Phase 2
GLK-302
pilocarpine
Presbyopia
$GKOS
GLAUKOS Corp
Phase 2
GLK-321
Demodex Blepharitis
$GKOS
GLAUKOS Corp
Phase 2
GLK-401
Age Related Macular Degeneration
$GKOS
GLAUKOS Corp
Phase 2
GRF-312
Keratoconjunctivitis Sicca (Dry Eye)
$GRFS
Grifols SA
Phase 2
GS-030
Retinitis Pigmentosa (Retinitis)
GenSight Biologics SA
Phase 2
Gene Therapy to Activate Retinoschisin for X-Linked Retinoschisis
Retinal Degeneration
National Eye Institute
Phase 2
H-1337
Open-Angle Glaucoma
D. Western Therapeutics Institute Inc
